NHIQ — Nanthealth Income Statement
0.000.00%
- $0.82m
- $319.21m
- $67.00m
- 32
- 82
- 32
- 46
Annual income statement for Nanthealth, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2018 December 31st | R2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 89.5 | 77.4 | 73.2 | 62.6 | 67 |
Cost of Revenue | |||||
Gross Profit | 45.2 | 43.3 | 43.9 | 34.8 | 38.2 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 140 | 112 | 99.4 | 104 | 119 |
Operating Profit | -50.7 | -34.4 | -26.3 | -40.9 | -51.5 |
Total Net Non Operating Interest Income / Expense | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -194 | -66.4 | -88 | -58.5 | -68.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -190 | -65.4 | -88.4 | -58.6 | -67.8 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | -192 | -62.8 | -56.3 | -58.3 | -67.8 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -192 | -62.8 | -56.3 | -58.3 | -67.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -26.2 | -8.44 | -11.9 | -7.65 | -8.7 |